Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease colorectal cancer
Symptom C0009324|ulcerative colitis
Sentences 44
PubMedID- 22610004 Challenges in calculating the risk for colorectal cancer in patients with ulcerative colitis.
PubMedID- 23446340 The risk of colorectal cancer in patients with long-standing ulcerative colitis or colonic crohn's disease is increased.
PubMedID- 25649787 Despite a low overall risk of colorectal cancer in patients with ulcerative colitis of relatively short duration, there is evidence that malignancies may be missed in that initial window.
PubMedID- 25888857 Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case.
PubMedID- 24496155 Although only 1% of all cases of colorectal cancer (crc) occur in patients with ulcerative colitis (uc) or crohn's disease (cd), patients with ibd represent one of the highest risk groups for developing this dreaded complication.
PubMedID- 25280558 The risk of colorectal cancer in patients with ulcerative colitis.
PubMedID- 25823771 It has been more than 40 years since the colonoscopic surveillance program for colorectal cancer (crc) in patients with long-standing ulcerative colitis (uc) was introduced (1).
PubMedID- 19906011 The development of colorectal cancer in ulcerative colitis is a function of disease duration, with the risk approaching 14% at 25 years.
PubMedID- 23118901 Inflammation plays a crucial role in the cancer development .
PubMedID- 20656250 The incidence of colorectal cancer associated with ulcerative colitis (uc) increases with time.
PubMedID- 25981516 Psc is a premalignant condition, associated with higher rates of hepatobiliary and colorectal cancer in patients with ulcerative colitis (uc).
PubMedID- 25834332 Aim: to determine the incidence and risk factors for colorectal cancer (crc) in patients with ulcerative colitis from a low prevalence region for crc.
PubMedID- 22292619 This article attempts to give an overview of current research of dysplasia and prevention/management of dysplasia and colitis-associated colorectal cancer in ulcerative colitis.
PubMedID- 21873166 Clinical course of colorectal cancer in patients with ulcerative colitis.
PubMedID- 23435402 Five-year mortality in colorectal cancer patients with ulcerative colitis or crohn's disease: a nationwide population-based cohort study.
PubMedID- 26357617 Risk factors for developing cca in psc patients include elevated serum bilirubin, chronic ulcerative colitis with colorectal cancer or dysplasia, variceal bleeding, proctocolectomy, and polymorphisms of the natural killer group 2, member d (nkg2d) gene (encoding a protein involved in nk cell activity).78, 82, 83 the duration of psc may not be a risk factor for the development of cca, which is contrary to the risk factors of neoplasia in inflammatory bowel disease.77 it is suggested that dominant strictures, defined as a common bile duct stenosis with less than 1.5 mm diameter remaining in the common bile duct or a common hepatic duct stenosis close to the bifurcation leaving less than 1.0 mm diameter of the common hepatic duct,84, 85 may serve as primary indicators of concomitant cca.86 it is very challenging to distinguish between benign strictures from psc activity and cca as they can have similar characteristics on imaging.
PubMedID- 25797989 Surveillance colonoscopy (sc) is considered important for the early detection and treatment of colorectal cancer (crc) in patients with ulcerative colitis (uc).
PubMedID- 21466491 How to manage the risk of colorectal cancer in ulcerative colitis.
PubMedID- 22289873 Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.
PubMedID- 24262637 Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis.
PubMedID- 23139655 Surgical procedure for sporadic colorectal cancer in patients with mild ulcerative colitis.
PubMedID- 23867875 Methylated eyes absent 4 (eya4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
PubMedID- 23295694 An average of 1.6% of patients with ulcerative colitis was diagnosed with colorectal cancer during 14 years of follow-up in population-based cohorts.
PubMedID- 22552273 Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
PubMedID- 20157368 In patients with inflammatory bowel disease such as ulcerative colitis, the risk of colorectal cancer begins to increase after 8 to 10 years and increases approximately 1% per year thereafter, particularly in patients with pancolitis .
PubMedID- 21618350 Background: chronic ulcerative colitis (uc) is associated with an increased colorectal cancer risk which may be secondary to repetitive mucosal injury.
PubMedID- 24766737 The pathogenesis of colorectal cancer in patients with ulcerative colitis is triggered by inflammation-dependent mechanisms 4.
PubMedID- 23459532 Surgical treatment of colorectal cancer associated with ulcerative colitis.
PubMedID- 20698214 Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in japan.
PubMedID- 25003294 Dysplasia in ulcerative colitis as a predictor of unsuspected synchronous colorectal cancer.
PubMedID- 21647200 Although progress has been made in the understanding of inflammation-driven carcinogenesis, markers based on these findings possess insufficient sensitivity or specificity to be usable as reliable biomarkers for risk of colorectal cancer development in patients with ulcerative colitis.
PubMedID- 21089179 The risk of colorectal cancer is increased in patients with long-standing ulcerative colitis.
PubMedID- 25347248 colorectal cancer in ulcerative colitis.
PubMedID- 25605985 Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis.
PubMedID- 21793125 Background: ulcerative colitis (uc) is associated with colorectal cancer.
PubMedID- 24733679 Risk of colorectal cancer in ulcerative colitis.
PubMedID- 21404516 colorectal cancer, in patients with ulcerative colitis, is detected in the resected tissue of approximately 5% of patients, according to the literature.
PubMedID- 23207933 The role of chemoprevention of colorectal cancer with 5-aminosalicylates in ulcerative colitis.
PubMedID- 24295648 Unique endoscopic findings of colitis-associated colorectal cancer in a patient with ulcerative colitis and lynch syndrome.
PubMedID- 21425209 Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and runx3 methylation.
PubMedID- PMC4070603 The risk of colorectal cancer in ulcerative colitis: a meta-analysis.
PubMedID- 21040676 Development of colorectal cancer in ulcerative colitis.
PubMedID- 23189226 Despite the fact that colorectal cancer complicating ulcerative colitis only accounts for approximately 2% of all cases of colorectal cancer in the general population, it is considered a serious complication and accounts for approximately 15% of all deaths associated with inflammatory bowel diseases.
PubMedID- 22156448 Does colorectal cancer in ulcerative colitis patients constitute a risk for chemotherapy refractoriness.

Page: 1